Varicella
Not yet recruitingStudy on the Immune Response and Safety of a Second Dose of Investigational Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children
Study on the Immune Response and Safety of a Second Dose of Investigational Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children
- Disease:Varicella
- Substances:GSKVX000000025896Varicella virus Oka/Merck strain (live, attenuated)+1
Denmark- Participants:0–17 years · Healthy volunteers
- Substances:GSKVX000000025896
- Sponsor:GlaxoSmithKline Biologicals




